Skip to main content

Table 5 Risk factors for tumor recurrence in HCC patients with portal vein invasion by univariate analysis

From: C-reactive protein may be a prognostic factor in hepatocellular carcinoma with malignant portal vein invasion

Variables

Hazard ratio

95% confidence interval

P value

Gender - Female

0.657

0.313–1.376

0.265

Age

0.973

0.946–1.000

0.052

AFP

1.000

1.000–1.000

0.005

PIVKA-II

1.001

1.000–1.001

0.128

Locoregional therapy

1.495

0.848–2.634

0.165

White blood cells

0.961

0.835–1.107

0.582

Hemoglobin

1.010

0.853–1.195

0.909

Platelet counts

1.000

0.998–1.003

0.821

INR

6.056

0.254–144.219

0.266

Albumin

0.533

0.290–0.980

0.043

Total bilirubin

1.047

0.654–1.676

0.849

AST

1.005

0.999–1.011

0.103

ALT

1.002

0.996–1.008

0.565

ALP

1.002

0.995–1.008

0.643

Creatinine

0.427

0.091–2.004

0.281

Estimated GFR

1.015

0.997–1.033

0.102

GGT

1.000

0.998–1.001

0.739

CRP

1.133

1.028–1.249

0.012

Operation (non-anatomical)

1.473

0.863–2.515

0.156

Hepatectomy (minor)

0.922

0.367–2.315

0.863

Maximum tumor size

1.003

0.997–1.010

0.282

Grade (3 and 4)

0.627

0.311–1.267

0.194

Cirrhosis

1.426

0.879–2.314

0.150

Capsule formation

1.020

0.353–2.941

0.971

Capsular invasion

0.715

0.439–1.165

0.178

Bile duct invasion

0.752

0.302–1.873

0.540

Serosa involvement

5.863

1.372–25.058

0.017

Intrahepatic metastasis

1.787

1.098–2.910

0.020

Multicentric occurrence

0.048

0.00–195.191

0.474

Margin (mm)

1.006

0.986–1.026

0.566

  1. AFP, Alpha-fetoprotein; ALP, Alkaline phosphate; ALT, Alanine aminotransferase; AST, Aspartate aminotransferase; CRP, C-reactive protein; GFR, Estimated glomerular filtration rate; GGT, Gamma-glutamyl transferase; INR, International normalized ratio; PIVKA-II, Protein induced by vitamin K antagonist-II.